Clinical Trials Browser

Unknown × NSCLC × pembrolizumab × Clear all

NCT04164745 2019-11-15

Efficacy and Safety Study of Anlotinib With Pembrolizumab in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Non-small Cell Lung Cancer

Phase 2 Unknown

NSCLC